<DOC>
	<DOCNO>NCT00983060</DOCNO>
	<brief_summary>This study design identify dose NIM811 good safety profile , well tolerate co-administered SOC , provide clinically meaningful effect viral load reduction compare SOC alone . This information use support dos select future study .</brief_summary>
	<brief_title>Adaptive-design Dose Finding Study Assess Antiviral Efficacy Safety NIM811 Administered Combination With Standard Care ( SOC ) Relapsed Hepatitis C Virus 1 ( HCV-1 ) Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Inclusion criterion : Patients eligible inclusion study fulfill follow criterion : chronic hepatitis C genotype1 HCVRNA ≥ 4 x 105 IU/mL screen Recipient prior long act interferon ribavirin treatment least 12 week , document negative serum HCV RNA treatment , subsequently become serum HCV RNA positive stopping treatment ( `` relapser '' ) . Patients must treatment least 3 month prior start study ( Visit Exclusion criterion : Use HCV treatment ≤ 3months prior study start Prior receipt investigational antiHCV therapy IFN RBV Women childbearing potential unless postmenopausal use predefined acceptable method contraception Pregnant breastfeed woman Evidence cirrhosis , hepatic decompensation , HCV liver disease , HBV HIV infection Specified abnormalities lab value amongst others hemoglobin , WBC , ANC , platelets History treatment depression Steroid/immunosuppression drug use 3 month prior study start Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>NIM811</keyword>
	<keyword>chronic hepatitis</keyword>
	<keyword>chronic hepatitis C</keyword>
	<keyword>chronic hepatitis C genotype-1</keyword>
	<keyword>HCV</keyword>
	<keyword>HCV-1</keyword>
	<keyword>relapser</keyword>
</DOC>